首页 | 本学科首页   官方微博 | 高级检索  
检索        

顺铂、丝裂霉素及沙培林序贯胸腔注入治疗恶性胸腔积液20例疗效观察
引用本文:吕丽丽,朱述阳,杨荣礼,周晓兵.顺铂、丝裂霉素及沙培林序贯胸腔注入治疗恶性胸腔积液20例疗效观察[J].哈尔滨医药,2008,28(1):19-20.
作者姓名:吕丽丽  朱述阳  杨荣礼  周晓兵
作者单位:徐州医学院附属医院,江苏,徐州,221002
摘    要:目的观察沙培林联合顺铂、丝裂霉素治疗恶性胸腔积液的临床疗效。方法将40例恶性胸水患者随机分为序贯治疗组20例和常规治疗组20例。两组患者在胸腔闭式引流放尽胸水后,序贯治疗组注入顺铂、丝裂霉素和沙培林,常规治疗组注入顺铂、丝裂霉素治疗。结果序贯治疗组完全有效(CR)9例,部分有效(PR)9例,总有效率90%,常规治疗组CR6例,PR 7例,总有效率65%,两组比较差异有显著性(P<0.05)。结论沙培林、顺铂和丝裂霉素序贯治疗恶性胸腔积液疗效好,毒副作用少,有较高临床应用价值。

关 键 词:恶性胸腔积液  沙培林  顺铂  丝裂霉素  胸腔内化疗
文章编号:1001-8131(2008)01-0019-02
收稿时间:2007-11-14
修稿时间:2007年11月14

Clinical Observation on Treatment Efficacy of Malignant Pleural Effusion by the use of Integrative OK-432,Cisplatin and Mitomycin
LV Lili,ZHU Shuyang,YANG Rongli,ZHOU Xiaobing.Clinical Observation on Treatment Efficacy of Malignant Pleural Effusion by the use of Integrative OK-432,Cisplatin and Mitomycin[J].harbin medical journal,2008,28(1):19-20.
Authors:LV Lili  ZHU Shuyang  YANG Rongli  ZHOU Xiaobing
Abstract:Objective To observe the effects of OK-432 combined with cisplatin(DDP) and mitomycin(MMC) in the treatment of malignant hydrothorax.Methods Forty patients with malignant hydrothorax were randomly divided into the therapeutic group(OK-432 DDP MMC,20 patients) and the control group(DDP MMC,20 patients).After completely depleting malignant pleural effusion,the therapeutic group patients were slowly injected with OK-432 cisplatin mitomycin into the thoracic cavity and the control group were injected cisplatin mitomycin.Results The response rate of the therapeutic group was 90%(18/20) and the control group was 65%(13/20);P<0.05.Conclusion The therapeutic effect of OK-432 combining with cisplation and therapy is markedly effective for malignant pleural effusion,and the toxic reaction is lower.It has better clinical value.
Keywords:Malignant pleural effusion  OK-432  cisplatin  mitomycin  hydrothorax
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号